Clinical trials
Withdrawn Phase 2 Lymphoma, T-Cell, Cutaneous trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| M.D. Anderson Cancer Center | 1 |
| Stefan Schieke MD | 1 |
| University of Medicine and Dentistry of New Jersey | 1 |
| University of Texas Southwestern Medical Center | 1 |
| Virogen Biotechnology Inc. | 1 |
| Yale University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Cutaneous | 7 |
| Mycosis Fungoides | 5 |
| Sezary Syndrome | 4 |
| Burkitt Lymphoma | 2 |
| Hodgkin Disease | 2 |
| Immunoblastic Lymphadenopathy | 2 |
| Intraocular Lymphoma | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Lymphoma, Extranodal NK-T-Cell | 2 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.